Evidence map›Paper›PMID 40300883›Full record

ReviewMedical gas research2025

Oxygen therapy in the intensive care unit.

Ping Wang, Qixin Huang, Bin Liu, Qiangjun Xu, Xingsong Li, Guidong Feng, Yiming Liu

Abstract readReview
In one paragraph

Review in Medical gas research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ping WangDepartment of Emergency, ZhuJiang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China.
Qixin HuangDepartment of Emergency, ZhuJiang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China.
Bin LiuDepartment of Emergency, ZhuJiang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China.
Qiangjun XuDepartment of Emergency, ZhuJiang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China.
Xingsong LiDepartment of Emergency, The Second People's Hospital of Qingyuan City, Qingyuan, Guangdong Province, China.
Guidong FengDepartment of Emergency, The Second People's Hospital of Qingyuan City, Qingyuan, Guangdong Province, China.
Yiming LiuDepartment of Emergency and Disaster Medicine, Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong Province, China.ORCID 0009-0002-0176-8591

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxygen therapy is a crucial treatment method for maintaining vital signs in patients in the intensive care unit. However, several controversial issues have emerged regarding its clinical application. This article analyzes current research trends in oxygen therapy in the intensive care unit and provides guidance and recommendations. Relevant literature was retrieved from the Web of Science Core Collection, and keyword co-occurrence and highly cited literature hotspot analyses were conducted using VOSviewer 1.6.19 software. The key topics related to oxygen therapy in the intensive care unit primarily focus on four areas: oxygen therapy and mechanical ventilation in the intensive care unit, extracorporeal membrane oxygenation therapy for coronavirus disease 2019 and its role in reducing mortality, research on hypoxia and oxygen saturation monitoring, and oxygen inhalation therapy in the intensive care unit. The analysis of highly cited literature indicates that the main research hotspots regarding oxygen therapy used in the intensive care unit focus primarily on conservative oxygen therapy, high-flow nasal oxygen therapy, comparisons of high- and low-oxygenation strategies, and research on hyperbaric oxygen therapy. First, the potential of conservative oxygen therapy to reduce mortality rates in the intensive care unit has attracted considerable attention; however, further clinical studies are needed to validate its optimal parameters and suitable patient populations. Second, high-flow nasal oxygen therapy has been shown to be effective in alleviating respiratory distress and reducing the need for intubation. This therapy can deliver oxygen flows of up to 60 L/min, effectively improving respiratory distress and decreasing intubation demands. In patients subjected to high-risk extubation, the combination of high-flow nasal oxygen therapy and noninvasive ventilation significantly lowers the rate of reintubation, making the combined approach one of the best strategies to prevent respiratory failure after extubation in the intensive care unit. Third, there are differences between lower and higher oxygenation strategies regarding their effects on patient mortality, long-term outcomes, and clinician preferences; however, there is currently no clear evidence indicating which strategy is superior. Clinicians' preferences regarding various oxygenation targets may impact the design of future studies. Finally, hyperbaric oxygen therapy is recognized as an effective supportive treatment for various critical conditions and has significant application value in acute severe traumatic brain injury, cerebral resuscitation, and cardiopulmonary resuscitation. Currently, researchers are continually exploring the latest oxygen therapies in the intensive care unit. Several randomized controlled clinical trials investigating automated oxygen control, novel high-flow nasal oxygen therapy, and combined oxygen therapy are underway. The results of these trials should be closely observed. Overall, this article provides a systematic review and valuable reference for the scientific and rational application of oxygen therapy in the intensive care unit. Future research should focus on verifying the optimal parameters of conservative oxygen therapy, assessing oxygen needs in different patient populations, evaluating the long-term effects of oxygen treatment, and developing novel oxygen therapy technologies and devices.

Indexed as

Intensive Care UnitsOxygen Inhalation TherapyCOVID-19Extracorporeal Membrane OxygenationHumansOxygenRespiration, ArtificialSARS-CoV-2Oxygenextracorporeal membrane oxygenationhigh-flow nasal oxygen therapyhyperbaric oxygenintensive care unitmortality ratenoninvasive ventilationoxygenoxygenationoxygen concentrationrespiratory distress

Identifiers

PMID40300883
PMCPMC12124703

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.